The Drug Commission of the German Medical Association informs physicians comprehensively about drug therapy and drug safety. By giving science-based recommendations, the commission contributes to the evidence-based use of medicines.
Prof. Dohle will advise the Drug Commission of the German Medical Association in particular on the topic of risk communication. „A clear and comprehensible communication of risks and benefits is essential for safe drug therapy. My aim is to communicate scientific findings in such a way that they can be used as effectively as possible in practice.“, says Prof. Simone Dohle.